Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease

Pediatric Research

Volumn 53, Issue 3, 2003, Pages 403-410

  Yoshioka, Takeshi ^a   Matsutani, Takaji ^a   Toyosaki Maeda, Tomoko ^a   Suzuki, Hiroyuki ^b   Uemura, Sigeru ^b   Suzuki, Ryuji ^a   Koike, Michio ^b   Hinuma, Yorio ^a  

^a SHIONOGI AND CO LTD   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; STREPTOCOCCUS ANTIGEN; T LYMPHOCYTE RECEPTOR; TOXIC SHOCK SYNDROME TOXIN 1;

ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HUMAN; INFANT; MALE; MITOGENESIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHILD, PRESCHOOL; EXOTOXINS; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-DR ANTIGENS; HUMANS; INFANT; MALE; MEMBRANE PROTEINS; MUCOCUTANEOUS LYMPH NODE SYNDROME; STREPTOCOCCAL INFECTIONS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0037372421     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000049668.54870.50     Document Type: Article

References (35)

1. Kawasaki T 1967 Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [Japanese]. Jpn J Allergy 16:178-222
2. Terai M, Kohono Y, Nizawa K, Toba T, Sakurai N, Nakajima H 1987 Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 60:555-559
3. Furukawa S, Matubara T, Yabuta K 1992 Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child 67:706-708
4. Leung DYM, Kurt-Jones E, Newburger JW, Cotran RS, Burns JC, Pober JS 1989 Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 338:1298-1302
5. Maury CPJ, Salo E, Pelkonen E 1989 Elevated circulating tumor necrosis factor-a in patients with Kawasaki disease. J Lab Clin Med 113:651-654
6. Matsubara T, Furukawa S, Yabuta S 1990 Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-g in Kawasaki disease. Clin Immunol Immunopathol 56:29-36
7. Todd J, Fishaut M 1978 Toxic shock syndrome associated phage-group 1-staphylococci. Lancet 2:1116-1118
8. Torres-Martinez C, Mehta D, Butt A, Levin M 1992 Streptococcus associated toxic shock. Arch Dis Child 67:126-130
9. Cone LA, Woodard DR, Schlievert PM, Tomory GS 1987 Clinical and bacteriological observations of toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 317:146-149
10. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DYM 1992 Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A 89:4066-4070
11. Abe J, Kotzin BL, Meissner C, Melish ME, Masato T, Fuluton D, Romagne F, Malissen B, Leung DYM 1993 Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 177:791-796
12. Curtis N, Zheng R, Lamb JR, Levin M 1995 Evidence for superantigen mediated process in Kawasaki disease. Arch Dis Child 72:308-311
13. Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB 1995 Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 155:5018-5021
14. Choi Y, Lafferty JA, Clements JR, Todd JK, Gelfand EW, Kappler J, Marrack P, Kotzin BL 1990 Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med 172:981-984
15. Kotzin B, Leung D, Kappler J, Marrack P 1994 Superantigens and their potential role in human disease. Adv Immunol 57:99-166
16. Toyosaki T, Yoshioka T, Tsuruta Y, Yutsudo T, Iwasaki M, Suzuki R 1996 Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B, and C. Eur J Immunol 26:2693-2701
17. Yoshioka T, Matsutani T, Iwagami S, Toyosaki-Maeda T, Yutsudo T, Tsuruta Y, Suzuki H, Uemura T, Takeuchi T, Koike M, Suzuki R 1999 Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology 96:465-472
18. Tsuruta Y, Iwagami S, Furue S, Teraoka H, Yosida T, Sakata T, Suzuki R 1993 Detection of human T cell receptor cDNAs (a, b, g and d) by ligation of a universal adaptor to variable region. J Immunol Methods 161:7-21
19. Tsuruta Y, Yoshioka T, Suzuki R, Sakata T 1994 Analysis of the population of human T cell receptor γ and δ chain variable region subfamilies by reverse dot blot hybridization. J Immunol Methods 169:17-23
20. Yoshioka T, Matsutani T, Iwagami S, Tsuruta Y, Kanesige T, Toyosaki T, Suzuki R 201 1997 Quantitative analysis of the usage of human T cell receptor a and b chain variable regions by reverse dot blot hybridization. J Immunol Methods 201:145-155
21. Matsutani T, Yoshioka T, Tsuruta Y, Iwagami S, Suzuki R 1997 Analysis of TCRAV and TCRBV repertoires in healthy individuals by microplate hybridization assay. Hum Immunol 56:57-69
22. Horiuchi T, Hirokawa M, Kawabata Y, Kitabayashi A, Matsutani T, Yoshioka T, Tsuruta Y, Suzuki R, Miura AB 2001 Identification of the T cell clones expanding within both CD8+CD28+ and CD8+CD28- T cell subsets in recipients of allogenic hematopoietic cell grafts and its implication in post-transplant skewing of T cell receptor repertoire. Bone Marrow Transplant 27:731-739
23. Kaneshige T, Hashimoto M, Matsumoto Y, Kinoshita T, Hirasawa T, Uchida K, Inoko H 1994 Serological and nucleotide sequencing analysis of novel DR52-asociated DRB1 allele with 'NJ25' specificity, designated DRB*1307. Hum Immunol 41:151-159
24. Bodmer JB, Steven GE, Ekkehard D, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR, Pharman P, Sasazuki T, Schreudr GMTH, Strominger JL, Svejgaard A, Terasaki PI 1997 Nomenclature for factors of HLA system, 1996. Tissue Antigens 49:297-321
25. Morita A, Imada Y, Igarashi H, Yutsudo T 1997 Serologic evidence that streptococcal superantigens are not in the pathogenesis of Kawasaki disease. Microbiol Immunol 41:895-900
26. Melish ME 1981 Kawasaki syndrome: a new infectious disease. J Infect Dis 143:317-324
27. Li Y, Li H, Dimasi N, McCormick JK, Martin R, Schuck P, Schlievert PM, Mariuzza RA 2001 Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity 14:93-104
28. Takata H, Suzuki M, Ishii T, Sekiguchi S, Iri H 1987 Influence of major histocompatibility complex region genes on human longevity among Okinawan-Japanese centenarians and nonagerians. Lancet 2:824-826
29. Higuchi T, Seki N, Yamada S, Kimura A, Kato H, Itoh K 1998 Polymorphism of 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51:605-612
30. Watanabe-Ohnishi R, Low DE, McGeer A, Stevens DL, Schlievert PM, Newton D, Schwartz B, Kreiswirth B, Kotb M 1995 Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis 171:274-275
31. Mascini EM 1997 Association with a lack of anti-exotoxin antibodies. In: Horaud R (ed) Streptococci and the Host. Plenum Press, New York, pp 921-922
32. Abe Y, Nakano S, Nakahara T, Kamezawa Y, Kato I, Ushijima H, Yoshino K, Ito S, Noma S, Okitsu S 1990 Detection of serum antibody by the antimitogen assay against streptococcal erythrogenic toxins. Age distribution in children and the relation to Kawasaki disease. Pediatr Res 27:11-15
33. Bonventre PF, Heeg H, Cullen C, Lian CJ 1993 Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in rabbit infection model of toxic shock syndrome. Infect Immun 61:793-799
34. Miethke T, Gaus H, Wahl C, Heeg K, Wagner H 1992 T cell dependent shock induced by a bacterial superantigen. Chem Immunol 55:172-184
35. Yamaoka J, Nakamura E, Takeda Y, Imamura S, Minato N 1998 Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C. Infect Immun 66:5020-5026